Filamentous bacteriophages replicate in pili-positive bacterial hosts, which are not lysed by the phage but instead secrete multiple copies of the phage displaying specific inserts. Phages that bind to the target molecule can be eluted and then amplified by growth in bacteria. This so-called "biopanning" process can be repeated several times until a population enriched with the best binders is obtained. The sequence of the binding peptide is determined by sequencing the portion of the phage genome encoding the peptide. Finally, the insert can be replicated as a recombinant peptide or a synthetic peptide. Through this method, specific and selective ligands targeting receptors can be identified.

In most display applications, the peptide is fused to the N-terminus or near the minor capsid protein pIII, followed by the capsid protein pVII. The advantage of pIII is that relatively large peptide and protein inserts can be incorporated without losing phage infectivity. In each phage particle, only about five copies of pIII are believed to be anchored at one tip of the particle. We have been using a phage display vector called fUSE5, in which every copy of pIII carries an insert. This results in multivalent display of the polypeptide. Multivalency is not necessarily a disadvantage, as over the past five years, we have identified several useful peptide ligands for different targets using this vector in both in vitro and in vivo applications. Several other vectors have been described that enable the display of inserts in a single copy of the phage capsid proteins pIII or pVII.

I. Protein Receptors Recognizing Short Peptide Sequences

When a protein of interest becomes available in purified form or can be expressed on cell surfaces after transfection, peptide libraries provide an opportunity to characterize the ligand-binding specificity of that protein. While protein-protein interactions in living cells are typically mediated through large surface areas, there are cases where short peptides participate in binding. Phage display peptide libraries are particularly well-suited for studying such peptide-directed interactions.A major application of phage-displayed peptide libraries is the determination of antibody epitopes. Antibodies recognize small peptide motifs based on just three or four conserved residues. Through epitope motifs revealed by phage display, it becomes possible to map the protein regions recognized by antibodies. Characterizing epitopes of antibodies associated with autoimmune diseases may yield important information about the immunogenic mechanisms of these diseases.

Phage particles displaying peptides can also be utilized in the opposite context to generate antibodies against the displayed peptides. Filamentous phages are potent immunogens, and antibodies can be raised specifically against the phage-displayed peptides alone.

II. Selection of Peptides for Binding Complex Biological Systems

In recent years, phage-displayed peptide libraries have been found useful for selecting peptides targeting more complex biological systems, such as human viruses, living cells, murine tissues, and tumors.  When working with such complex targets, it is necessary to employ guided phage selection protocols to enhance peptide-mediated specific binding over background phage adhesion. In one pioneering approach, cells transfected with the urokinase receptor gene were used to isolate peptide ligands binding to this receptor.  By employing two transfected cell lines from different species (one murine and one insect), the selection was specifically focused on urokinase receptor-binding peptides, as the receptor represented the only common feature between the two cell lines.  Interestingly, the isolated peptide motifs showed no sequence similarity to the known urokinase sequence that binds the receptor.  This cell surface-based heterologous receptor expression system has also been successfully applied to select peptides for melanocortin-1 receptor.

Another targeted selection strategy involves specific elution of bound phages using agents known to disrupt the interaction, such as specific antibodies or competing peptides.  For instance, human platelets served as targets to develop peptide antagonists for thrombin receptor.  Phages bound to platelets were eluted using a known thrombin receptor agonist peptide.

Antibody-assisted elution has been employed to identify peptides binding to different capsid proteins of human adenovirus.  Characterization of peptide-virus interactions may provide clues about which proteins can bind viruses and potentially serve as cell surface viral receptors.  Some isolated peptide sequences showed similarity to known adenovirus receptors, including integrins.  These virus-binding peptides hold therapeutic potential as they may interfere with infectivity by blocking viral attachment and/or internalization.For example, a cyclic peptide (CLRSGRGC) was identified by screening a phage library against human echovirus.  This peptide partially inhibited viral infectivity in human cells.  Notably, purified phage particles displaying such virus-targeting peptides themselves can also block viral infectivity.  Similarly, phages selected for hantavirus binding were shown to inhibit viral infectivity in cell culture.

III. Applications of Library-Derived Peptides: Integrins as Targets

To validate the binding of phage-displayed peptides to their targets, these peptides need to be produced either as synthetic peptides or as fusion proteins (e.g., in E. coli).  Typically, the optimal synthetic peptides are derived from phage sequences that show the highest affinity for the target and become enriched during clone sequencing.Integrin-binding peptide ligands obtained from phage display libraries can inhibit cell adhesion to extracellular matrix proteins and serve as valuable tools for studying the function of specific integrins involved in these interactions.  Furthermore, when synthetic peptides are incorporated into matrices, they support cell adhesion, enabling applications in artificial tissue engineering or transplantation.